Gain Therapeutics Newsroom

Gain Therapeutics Analyst Ratings

BenzingaJul 11 06:25 ET

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and Gain Therapeutics (GANX)

TipRanksJul 11 06:22 ET

Gain Therapeutics Analyst Ratings

BenzingaJul 2 06:15 ET

Gain Therapeutics Analyst Ratings

BenzingaMay 31 06:20 ET

Gain Therapeutics Analyst Ratings

BenzingaMay 28 06:34 ET

Buy Rating Affirmed for Gain Therapeutics Amidst Promising Clinical Trials and Strong Financial Health

TipRanksMay 15 14:30 ET

Gain Therapeutics Analyst Ratings

BenzingaMay 15 07:14 ET

Buy Rating Affirmed for Gain Therapeutics Amid Positive Clinical and Financial Performance

TipRanksMay 15 06:40 ET

Buy Rating Affirmed for Gain Therapeutics on Promising GT-02287 Clinical Progress

TipRanksApr 25 12:25 ET

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)

TipRanksApr 25 06:43 ET

Gain Therapeutics Analyst Ratings

BenzingaApr 25 06:42 ET

Gain Therapeutics Analyst Ratings

BenzingaApr 23 08:24 ET

Oppenheimer Remains a Buy on Gain Therapeutics (GANX)

TipRanksApr 23 07:50 ET

Gain Therapeutics Analyst Ratings

BenzingaApr 1 07:16 ET

Optimistic Buy Rating for Gain Therapeutics Backed by Strong Financials and Promising Parkinson's Drug Candidate GT-02287

TipRanksMar 27 13:30 ET

Chardan Capital Reiterates Buy on Gain Therapeutics, Maintains $6 Price Target

BenzingaMar 27 04:45 ET

Gain Therapeutics Analyst Ratings

BenzingaMar 27 04:38 ET

Buy Rating for Gain Therapeutics Backed by Strong Preclinical Data and Promising Parkinson's Candidate GT-02287

TipRanksFeb 7 06:16 ET

Buy Rating Affirmed: Gain Therapeutics' Promising GT-02287 Advances Towards Key Clinical Milestones in Parkinson's Disease Treatment

TipRanksFeb 1 15:35 ET

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Humana (HUM) and Boston Scientific (BSX)

TipRanksFeb 1 06:50 ET